Screener
BioCryst Pharmaceuticals BCRX Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's inventories?
- BioCryst Pharmaceuticals (BCRX) reported inventories of $31.95M in Q2 2026.
- How has BioCryst Pharmaceuticals's inventories changed year-over-year?
- BioCryst Pharmaceuticals's inventories increased by 43.9% year-over-year, from $22.21M to $31.95M.
- What is the long-term trend for BioCryst Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's inventories has grown at a 27.8% compound annual growth rate (CAGR), from $7.04M to $23.99M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about BioCryst Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude